Download FREE Practo app
Get ₹200 HealthCash
Crp from 12.5 to 105 after covishield
Hello,
My Crp level went from 12.5 to 105 in 10days after covishield vaccine. Is this matter of concern? Will it be solved on its own?? I have fever above 100. It reduces after taking paracetamol, and next day comes again. Today is 14th day after vaccine.
I am rheumatic arthritis patient.
Answers (2)
Like the answers? Consult privately with the doctor of your choice
Dr. Sivabal V
Cardiologist
11 yrs exp
Thiruvananthapuram
The CRP elevation and persistent fever is unlikely to be due to vaccination.
Next Steps
please consult
Answered
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
YES
NO
Didn't find the answer you are looking for?
Talk to experienced doctor online and get your health questions answered in just 5 minutes.
+106
Dr. Lokanath M
Cardiologist
5 yrs exp
Kottayam
Please check for covid infection... Vaccine fever will not last long..
Answered
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
YES
NO
Articles you may like
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
The question asked on this page is a free question. You can ask a free health question by downloading the Practo app.
Articles you may like
Tell us what's troubling you
Tell us what's troubling you
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.